Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.254
+0.044 (+3.60%)
Streaming Delayed Price
Updated: 1:05 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm
June 11, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
June 11, 2021
From
The Schall Law Firm
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
10 Biggest Price Target Changes For Friday
June 11, 2021
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading....
Via
Benzinga
66 Biggest Movers From Yesterday
June 11, 2021
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,...
Via
Benzinga
Why Ocugen Plummeted by Nearly 30% Today
June 10, 2021
The company won't be getting emergency use authorization for Covaxin after all.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
June 10, 2021
From
The Schall Law Firm
Via
Business Wire
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Materialise Shares Slide
June 10, 2021
Toward the end of trading Thursday, the Dow traded up 0.25% to 34,531.98 while the NASDAQ rose 0.72% to 14,011.75. The S&P also rose, gaining 0.51% to 4,241.13. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
EQUITY ALERT: Rosen Law Firm Encourages Ocugen, Inc. Investors with Losses to Inquire About Class Action Investigation – OCGN
June 10, 2021
From
Rosen Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 10, 2021
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares...
Via
Benzinga
Mid-Day Market Update: Yiren Digital Rises Following Q1 Results; Ocugen Shares Slide
June 10, 2021
Midway through trading Thursday, the Dow traded up 0.35% to 34,568.37 while the NASDAQ rose 0.5% to 13,981.31. The S&P also rose, gaining 0.46% to 4,238.79. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
42 Stocks Moving In Thursday's Mid-Day Session
June 10, 2021
Gainers Orphazyme A/S (NASDAQ: ORPH) surged 105% to $10.71. Medley Management Inc. (NASDAQ: MDLY) shares jumped 78% to $10.39 after gaining 9% on Wednesday. Medley LLC recently...
Via
Benzinga
Making Money in the Stock Market Is Easy -- If You Avoid This 1 Thing
June 10, 2021
Get-rich-quick strategies rarely work.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Increases to 5%
June 10, 2021
Following the market opening Thursday, the Dow traded up 0.54% to 34,632.83 while the NASDAQ rose 0.72% to 14,011.98. The S&P also rose, gaining 0.58% to 4,243.96. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
June 10, 2021
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn't be applying for a crucial authorization.
Via
InvestorPlace
Exposures
COVID-19
Why Ocugen Shares Are Getting Hammered Today
June 10, 2021
Ocugen Inc (NASDAQ: OCGN) shares were trading 22.18% lower off the open Thursday at $7.24 after the company announced it will pursue a biologics license application path for...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 10, 2021
Gainers Verona Pharma (NASDAQ:VRNA) stock moved upwards by 15.2% to $7.5 during Thursday's pre-market session. The market value of their outstanding shares is at $434....
Via
Benzinga
Could Ocugen Be a Millionaire-Maker Stock?
June 09, 2021
The ability of this biotech to sell its coronavirus vaccine in a timely manner has caused a lot of headaches for investors.
Via
The Motley Fool
Exposures
COVID-19
3 Tips for COVID Vaccine Stock Investing Right Now
June 08, 2021
Coronavirus vaccine investing is far from over.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
Why Ocugen Stock Fell 31.1% in May
June 07, 2021
The biopharmaceutical company, known for its portfolio of eye therapy drugs, has a COVID-19 vaccine in the works.
Via
The Motley Fool
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's After-Market Session
June 07, 2021
Gainers Nymox Pharmaceutical (NASDAQ:NYMX...
Via
Benzinga
60 Biggest Movers From Yesterday
June 08, 2021
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle...
Via
Benzinga
OCGN stock: The Big COVAXIN News Boosting Ocugen Today
June 07, 2021
Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada.
Via
InvestorPlace
When It Comes to Ocugen Stock I’m Damned If I Do or Don’t
June 06, 2021
After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits?
Via
InvestorPlace
This New Vaccine Market Could Be Bigger for Ocugen Than the U.S.
June 06, 2021
Ocugen is casting a wider net.
Via
The Motley Fool
Exposures
COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
June 03, 2021
It seems as though INO stock will have a tough time getting and staying in double digits
Via
InvestorPlace
The Same Problems Persist for Ocugen in Marketing Covaxin
June 03, 2021
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward in the long term.
Via
InvestorPlace
Exposures
COVID-19
28 Stocks Moving in Thursday's Pre-Market Session
June 03, 2021
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14...
Via
Benzinga
Did the FDA Slam the Door on Ocugen's Chances of Winning Authorization for Covaxin?
June 03, 2021
The agency's revised emergency-authorization guidance for COVID-19 vaccines appears to present a significant hurdle for Ocugen.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock
June 03, 2021
The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.